dibehenyldimethylammonium bromide | 42831-18-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: dibehenyldimethylammonium bromide
• 英文别名: N-Docosyl-N,N-dimethyldocosan-1-aminium bromide；di(docosyl)-dimethylazanium;bromide
• CAS: 42831-18-5
• 化学式: Br*C₄₆H₉₆N
• 分子量: 743.179
• InChiKey: QBGCXIWJBVFOFO-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  13.71
• 重原子数：
  48
• 可旋转键数：
  42
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4,5-双(苯甲酰硫基)-1,3-二硫杂环戊烯-2-硫酮 、 dibehenyldimethylammonium bromide 、 nickel dichloride 在 碘 、 sodium methylate 、 sodium iodide 作用下， 以 not given 为溶剂， 生成 (C22H45)2Me2NNi(dmit)2
  参考文献：
  名称：

  二烷基二甲基铵-Ni(dmit)2配合物的导电Langmuir-Blodgett薄膜

  摘要：

  描述了二烷基二甲基铵-Ni(dmit)2 络合物的导电LB 薄膜。前体 1:1 配合物被转移到基材上并通过溴氧化转化为导体。取决于烷基链的长度，薄膜的体电导率为 10-3 至 10-1 S/cm。还检查了氧化过程中的光谱变化。

  DOI：

  10.1246/cl.1988.1667

文献信息

• ANTITHROMBOTIC COMPOSITIONS AND MEDICAL INSTRUMENTS CONTAINING THE SAME
  申请人：Toyo Boseki Kabushiki Kaisha

  公开号：EP1402871A1

  公开（公告）日：2004-03-31

  The present invention provides an antithrombotic composition containing an ionic complex formed from an organic cation mixture and heparin or a heparin derivative, wherein the organic cation mixture is a mixture of at least two ammonium salts, provided that the above-mentioned organic cation mixture is not a mixture of a didodecyldimethylammonium salt and at least one kind of an ammonium salt selected from ammonium salts having four aliphatic groups, wherein the four aliphatic groups have 30 to 38 carbon atoms in total and at least two of the four aliphatic groups are each an alkyl group having not less than 10 carbon atoms. This antithrombotic composition can impart superior antithrombotic property to a medical device over a prolonged period.

  本发明提供了一种含有由有机阳离子混合物和肝素或肝素衍生物形成的离子复合物的抗血栓组合物，其中有机阳离子混合物是至少两种铵盐的混合物、条件是上述有机阳离子混合物不是十二烷基二甲基铵盐和至少一种选自具有四个脂肪族基团的铵盐的铵盐的混合物，其中四个脂肪族基团共有 30 至 38 个碳原子，且四个脂肪族基团中至少有两个基团分别是具有不少于 10 个碳原子的烷基。这种抗血栓组合物可为医疗设备提供长期的卓越抗血栓性能。
• BIOMATERIAL
  申请人：FUJIFILM Corporation

  公开号：EP3854422A1

  公开（公告）日：2021-07-28

  The present invention provides a biomaterial that is excellent in scratch resistance and retention in a case of being brought into contact with water. The biomaterial according to the embodiment of the present invention is a biomaterial including a neutral acyl lipid, at least one selected from the group consisting of a phospholipid and a quaternary ammonium salt, and a carboxyvinyl polymer. The neutral acyl lipid includes at least one selected from the group consisting of a neutral monoacyl lipid and a neutral diacyl lipid, and a content of the at least one selected from the group consisting of the neutral monoacyl lipid and the neutral diacyl lipid is 80% by mass to 100% by mass with respect to a total mass of the neutral acyl lipid.

  本发明提供了一种在与水接触的情况下具有优异抗划伤性和保持性的生物材料。根据本发明的实施方案，生物材料包括中性酰基脂质、至少一种选自磷脂和季铵盐组成的组以及羧基乙烯聚合物。中性酰基脂质包括至少一种选自中性单酰基脂质和中性二酰基脂质组成的组，且至少一种选自中性单酰基脂质和中性二酰基脂质组成的组的含量占中性酰基脂质总质量的 80% 至 100%。
• BIOLOGICAL MATERIAL
  申请人：FUJIFILM Corporation

  公开号：EP3950056A1

  公开（公告）日：2022-02-09

  There is provided a biomaterial that is excellent in retention in a case of being brought into contact with water. The biomaterial includes a neutral acyl lipid and an amphipathic block copolymer which contains a hydrophilic segment and a hydrophobic segment and in which a difference in ClogP value between the hydrophilic segment and the hydrophobic segment is more than 1.00, and in the biomaterial, a content of the amphipathic block copolymer is 1.0% to 20% by mass with respect to a total mass of a solid content of the biomaterial.

  本发明提供了一种在与水接触的情况下保持性能优异的生物材料。该生物材料包括中性酰基脂和两性嵌段共聚物，其中两性嵌段共聚物包含亲水段和疏水段，亲水段和疏水段之间的 ClogP 值之差大于 1.00，在该生物材料中，两性嵌段共聚物的含量占生物材料固体总含量的 1.0% 至 20%。
• Antithrombotic compositions and medical instruments containing the same
  申请人：——

  公开号：US20040213818A1

  公开（公告）日：2004-10-28

  The present invention provides an antithrombotic composition containing an ionic complex formed from an organic cation mixture and heparin or a heparin derivative, wherein the organic cation mixture is a mixture of at least two ammonium salts, provided that the above-mentioned organic cation mixture is not a mixture of a didodecyldimethylammonium salt and at least one kind of an ammonium salt selected from ammonium salts having four aliphatic groups, wherein the four aliphatic groups have 30 to 38 carbon atoms in total and at least two of the four aliphatic groups are each an alkyl group having not less than 10 carbon atoms. This antithrombotic composition can impart superior antithrombotic property to a medical device over a prolonged period.

  本发明提供了一种含有由有机阳离子混合物和肝素或肝素衍生物形成的离子复合物的抗血栓组合物，其中有机阳离子混合物是至少两种铵盐的混合物、条件是上述有机阳离子混合物不是十二烷基二甲基铵盐和至少一种选自具有四个脂肪族基团的铵盐的铵盐的混合物，其中四个脂肪族基团共有 30 至 38 个碳原子，且四个脂肪族基团中至少有两个基团分别是具有不少于 10 个碳原子的烷基。这种抗血栓组合物可为医疗设备提供长期的卓越抗血栓性能。
• OPAQUE CONDITIONING COMPOSITION
  申请人：UNILEVER PLC

  公开号：EP1104285A1

  公开（公告）日：2001-06-06